Organization | LTB4 Sweden AB

LTB4 Sweden AB Report issue

For profit Phase 2

Founded: Geras Sweden (2004)

Status: Defunct (2018)

Organization Overview

First Clinical Trial

2005

NCT00251537

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2005

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 2 Trials (1)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 2)

Infections (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 1
# of Trial APIs: 1